Octagon Capital Advisors as of March 31, 2025
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 34 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tourmaline Bio (TRML) | 11.7 | $64M | 4.1M | 15.70 | |
| Nuvation Bio *w Exp 02/10/202 (SNDX) | 8.8 | $48M | 27M | 1.76 | |
| Cogent Biosciences (COGT) | 8.4 | $46M | 2.1M | 21.87 | |
| Maze Therapeatics (MAZE) | 7.8 | $43M | 2.3M | 18.14 | |
| Dianthus Therapeutics (DNTH) | 6.9 | $38M | 2.1M | 18.49 | |
| Centessa Pharmaceuticals Sponsored Ads (GOSS) | 3.7 | $21M | 1.4M | 14.38 | |
| Mind Medicine Mindmed (MNMD) | 3.7 | $20M | 18M | 1.10 | |
| Taysha Gene Therapies (TSHA) | 3.2 | $18M | 2.4M | 7.33 | |
| Mind Medicine Mindmed Com New (CATX) | 3.2 | $18M | 3.0M | 5.85 | |
| Kalaris Therapeutics (KLRS) | 3.0 | $17M | 2.8M | 5.99 | |
| Neurogene (NGNE) | 2.9 | $16M | 1.4M | 11.54 | |
| Taysha Gene Therapies Com Shs (APGE) | 2.7 | $15M | 11M | 1.39 | |
| Nuvation Bio Com Cl A (SRRK) | 2.5 | $14M | 7.9M | 1.76 | |
| Verona Pharma Sponsored Ads (HUMA) | 2.5 | $14M | 217k | 63.49 | |
| Miragen Therapeutics (VRDN) | 2.5 | $14M | 905k | 15.21 | |
| Pharvaris N V (PHVS) | 2.4 | $13M | 308k | 42.09 | |
| Moonlake Immunotherapeutics Class A Ord (OCUL) | 2.1 | $12M | 296k | 39.07 | |
| Unicycive Therapeutics | 2.0 | $11M | 904k | 12.29 | |
| Atyr Pharma Com New (CRBP) | 2.0 | $11M | 3.6M | 3.02 | |
| Verona Pharma Plc ads (VRNA) | 1.9 | $11M | 329k | 32.15 | |
| Verastem Com New (IBRX) | 1.9 | $10M | 1.7M | 6.03 | |
| Centessa Pharmaceuticals Sponsored Ads Put Option (HLXB) | 1.6 | $8.6M | 600k | 14.38 | |
| Trevi Therapeutics (TRVI) | 1.5 | $8.1M | 4.6M | 1.75 | |
| Verastem (VSTM) | 1.4 | $7.9M | 625k | 12.58 | |
| Abivax Sa Sponsored Ads (CNTA) | 1.4 | $7.7M | 1.2M | 6.25 | |
| Merus N V (MRUS) | 1.3 | $7.0M | 5.1M | 1.37 | |
| Capricor Therapeutics (CAPR) | 1.1 | $6.1M | 450k | 13.48 | |
| Corbus Pharmaceuticals Hldgs Com New (KALV) | 1.1 | $5.9M | 1.1M | 5.31 | |
| Atyr Pharma (ATYR) | 1.0 | $5.7M | 10M | 0.57 | |
| Nuvation Bio (NUVB.WS) | 0.9 | $5.2M | 468k | 11.01 | |
| Perspective Therapeutics Com New (ERAS) | 0.9 | $4.8M | 2.3M | 2.13 | |
| Nuvation Bio (NUVB) | 0.7 | $3.9M | 481k | 8.03 | |
| Regulus Therapeutics | 0.6 | $3.5M | 303k | 11.71 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (MLTX) | 0.5 | $2.8M | 250k | 11.30 |
